MAPT and amyotrophic lateral sclerosis: On the contrary, the recent investigation of Illán-Gala et al. (2021) demonstrated higher plasma NFL levels in pathology-proven FTLD-TDP cases compared with pathological FTLD-tau cases, a difference which held true also after excluding cases with ALS-FTD from the FTLD-TDP neuropathological cohort.